[Comorbidity of tics and stuttering]

Area of Science:

• Neurology
• Pediatrics
• Speech-Language Pathology

Background:

• Stuttering is a complex speech disorder that can co-occur with other neurological conditions.
• Tic disorders are characterized by involuntary, repetitive movements or vocalizations.
• The comorbidity of stuttering and tics in children requires further clinical investigation.

Purpose of the Study:

• To investigate the clinical presentation and prevalence of stuttering in children diagnosed with tics.
• To evaluate the efficacy of Noofen in managing comorbid stuttering and tics in pediatric patients.

Main Methods:

• A cohort of 181 children aged 7-13 with tics was examined.
• Stuttering was identified in 23.2% of the participants.
• Thirty children with comorbid tics and stuttering were treated with Noofen.

Main Results:

• The prevalence of stuttering was significantly higher in children with tics compared to the general population.
• Stuttering was more frequent in children with transient tics than chronic tics, with neurotic stuttering being common.
• Noofen demonstrated high efficacy, reducing tics in 80% and stuttering in 66.7% of treated children.

Conclusions:

• Stuttering is a notable comorbidity in pediatric tic disorders.
• Noofen is an effective therapeutic agent for reducing both tic and stuttering symptoms in children.
• Clinical, psychological, and neurophysiological data support the positive impact of Noofen treatment.